03:40 PM EST - GeneNews Limited : provided an update and reported operational and financial results for the nine-month period ended September 30, 2015, for GeneNews and provided an update on the operations of its Innovative Diagnostics Laboratory, LLP, joint-venture. All dollar amounts are expressed in U.S. dollars. GeneNews' total revenues were approximately $0.3 million as compared to $1.6 million in the same period in 2014. The net loss for nine months in 2015 was approximately $4.5 million, or $0.09 loss per common share, as compared to a net loss of approximately $4.9 million, or $0.12 loss per common share, for the same period in 2014. GeneNews Limited
shares T.GEN are trading down $0.035 at $0.06.
